(Q42107088)

16 October 2017

In vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of hematogenous pulmonary infection (English)

1 reference

methicillin-resistant Staphylococcus aureus

16 October 2017

0 references

Staphylococcus aureus

1 reference

13

Shigeru Kohno

1 reference

16 October 2017

11

Koichi Izumikawa

1 reference

16 October 2017

8

Yoshifumi Imamura

1 reference

16 October 2017

10

Taiga Miyazaki

1 reference

16 October 2017

12

Hiroshi Kakeya

1 reference

16 October 2017

2

Katsunori Yanagihara

1 reference

16 October 2017

6

Yoshitomo Morinaga

1 reference

16 October 2017

4

Yohei Migiyama

1 reference

16 October 2017

1

Yosuke Harada

1 reference

16 October 2017

Koichi Yamada

3

1 reference

16 October 2017

Kentaro Nagaoka

series ordinal

5

1 reference

16 October 2017

Shigeki Nakamura

series ordinal

7

1 reference

16 October 2017

Hiroo Hasegawa

series ordinal

9

1 reference

16 October 2017

language of work or name

English

0 references

publication date

18 March 2013

1 reference

Antimicrobial Agents and Chemotherapy

16 October 2017

1 reference

16 October 2017

57

1 reference

16 October 2017

6

1 reference

16 October 2017

2841-2844

1 reference

Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

In vivo pharmacodynamic activity of daptomycin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Special issues in the management of infective endocarditis caused by gram-positive cocci

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Pharmacokinetics and inflammatory fluid penetration of intravenous daptomycin in volunteers

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3716188

Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23507279

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.02331-12

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

23507279

1 reference